MedTrace Logo

A Study of Octave System for Improving Lines and Wrinkles of the Décolleté

NCT04681352 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 99

Last updated 2024-01-18

Study results available
· View outcomes & findings →

Summary

To demonstrate the safety and effectiveness of the Octave System for improving lines and wrinkles of the décolleté.

Conditions

  • Décolleté Wrinkles

Interventions

DEVICE

Octave-Ultherapy treatment

Micro-focused ultrasound delivered below the surface of the skin.

Sponsors & Collaborators

  • Ulthera, Inc

    collaborator INDUSTRY

  • Merz North America, Inc.

    lead INDUSTRY

Principal Investigators

  • Merz Medical Expert · Merz North America, Inc.

Study Design

Allocation
NA
Purpose
TREATMENT
Masking
NONE
Model
SINGLE_GROUP

Eligibility

Min Age
35 Years
Max Age
65 Years
Sex
FEMALE
Healthy Volunteers
No

Timeline & Regulatory

Start
2020-12-29
Primary Completion
2021-11-24
Completion
2022-02-21
FDA Device
Yes

Countries

  • United States

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT04681352 on ClinicalTrials.gov